Polyrizon Ltd. (PLRZ) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Polyrizon Ltd. (PLRZ) closed at USD 10.41 on 2026-10-14, a change of +63.7 % over the past year, with a market capitalization of USD 24.31M.

Polyrizon Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Polyrizon Ltd. key figures

Previous close

USD 10.41 (2026-10-14)

1-year change

+63.7 %

Market cap

USD 24.31M

Enterprise value

USD 5.21M

P/E ratio (trailing)

-1.89

P/E ratio (forward)

n/a

EPS (trailing)

-5.31

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.87

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.76

Employees

2

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Polyrizon Ltd.

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Polyrizon Ltd. and compare it with other stocks.